Effect of adjuvants in the isotypes and bactericidal activity of antibodies against the transferrin-binding proteins of neisseria meningitidis

Vaccine

Volumn 16, Issue 17, 1998, Pages 1633-1639

  Gomez J A ^a   Hernandez E ^a   Criado, M T ^a   Ferreiros C M ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Adjuvant; Neisseria meningitidis; TbpA; TbpB; Transferrin binding protein; Vaccine

Indexed keywords

ADJUVANT; BACTERIAL PROTEIN; IMMUNOGLOBULIN G1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN PRESENTATION; ARTICLE; BACTERICIDAL ACTIVITY; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BLOOD BACTERICIDAL ACTIVITY; CARRIER PROTEINS; CROSS REACTIONS; IMMUNOGLOBULIN ISOTYPES; IRON-BINDING PROTEINS; MICE; MICE, INBRED BALB C; NEISSERIA MENINGITIDIS; TRANSFERRIN-BINDING PROTEINS;

EID: 0032192693     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00062-0     Document Type: Article

References (31)

1. 1 Lissolo, L., Maitre-Wilmotte, G., Dumas, P., Mignon, M., Danve, B. and Quentin-Millet, M.-J. Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines. Infect. Immun. 1995, 63, 884-890.
2. 2 Pintor, M., Perron, L., Gómez, J.A., Gorringe, A., Criado, M.T. and Ferreirós, C.M. Blocking of iron uptake by monoclonal antibodies specific for the Neisseria meningitidis transferrin-binding protein 2. J. Med. Microbiol. 1996, 45, 252-257.
3. 3 Pintor, M., Ferrón, L., Gómez, J.A., Powell, N.B.L., Ala'Aldeen, D.A.A., Borriello, S.P., Criado, M.T. and Ferreirós, C.M. Blocking of iron uptake from transferrin by antibodies against the transferrin binding proteins in Neisseria meningitidis. Microb. Pathog. 1996, 20, 127-139.
4. 4 Rokbi, B., Mignon, M., Maitre-Wilmotte, G., Lissolo, L., Danve, B., Caugant, D.A. and Quentin-Millet, M.-J. Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains. Infect. Immun. 1997, 65, 55-63.
5. 5 Frasch, C.E. Immunization against Neisseria meningitidis. In: Medical Microbiology (Eds Easmon, C.S.F. and Jeljaszewicz, J.). Academic Press, New York, 1983, pp. 115-144.
6. 6 Gorringe, A.R., Borrow, R., Fox, A.J. and Robinson, A. Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential. Vaccine 1995, 13, 1207-1212.
7. 7 Audibert, F.M. and Lise, L.D. Adjuvants: current status, clinical perspectives and future prospects. Immunol. Today 1993, 14, 281-284.
8. 8 Gupta, R.K. and Siber, G.R. Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 1995, 13, 1263-1276.
9. 9 Smith, P.K., Krohn, R.I., Hermason, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J. and Clenk, D.C. Measurement of protein using Bincinchoninic acid. Anal. Biochem. 1985, 150, 76-85.
10. 10 Ferrón, L., Ferreirós, C.M., Criado, MT. and Andrade, M.P. Purification of the Neisseria meningitidis transferrin binding protein-2 (TbpB) to homogeneity using column chromatography. FEMS Microbiol. Lett. 1993, 109, 159-166.
11. 11 Chase, M.W. Production of antiserum. Meth. Immunol. Immunochem. 1967, 1, 197-209.
12. 12 Fletcher, J.N., Zak, K., Virji, M. and Heckels, J.E. Monoclonal antibodies to gonococcal outer membrane protein I: location of a conserved epitope on protein IB. J. Gen. Microbiol. 1986, 132, 1611-1620.
13. 13 Mietzner, T.A., Barnes, R.C., Jeanlouis, Y.A., Shafer, W.H. and Morse, S.A. Distribution of an antigenically related iron-regulated protein among the Neisseria spp.. Infect. Immun. 1986, 51, 60-68.
14. 14 Laemli, U.K. Cleavage of structural proteins during the asembly of the head of the bacteriophage T4. Nature 1970, 277, 680-685.
15. 15 Pintor, M., Ferreirós, C.M., Criado, M.T. and Ferrón, L. Expression levels of human transferrin receptors in Neisseria species. J. Microbiol. Meth. 1992, 15, 321-326.
16. 16 Zollinger, W.D., Brandt, B.L., Tramont, E.C. and Dobek, A.S. Immune response to Neisseria meningitidis. In: Manual of Clinical Immunology (Eds Rose, N.R. and Friedman, H.). American Society for Microbiology, Washington, DC, 1980, pp. 446-453.
17. 17 Ala'Aldeen, D.A.A., Stevenson, P., Griffiths, E., Gorringe, A.R., Irons, L.I., Robinson, A., Hyde, S. and Borriello, S.P. Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Infect. Immun. 1994, 62, 2984-2990.
18. 18 Ferrón, L., Ferreirós, C.M., Criado, M.T. and Pintor, M. Reliability of laboratory models in the analysis of TbpB and other meningococcal antigens. FEMS Immunol. Med. Microbiol. 1994, 9, 299-306.
19. 19 Rokbi, B., Mazarin, V., Maitre-Wilmotte, G. and Quentin-Millet, M.-J. Identification of two major families of transferrin receptors among Neisseria meningitidis strains based on antigenic and genomic features. FEMS Microbiol. Lett. 1993, 110, 51-58.
20. 20 Ala'Aldeen, D.A.A. and Borriello, SP. The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains. Vaccine 1996, 14, 49-53.
21. 21 Ferrón, L., Ferreirós, C.M., Criado, M.T. and Pintor, M. Immunogenicity and antigenic heterogeneity of a human transferrin-binding protein in Neisseria meningitidis. Infect. Immun. 1992, 60, 2887-2892.
22. 22 Kenney, J.S., Hughes, B.W., Masada, M.P. and Allison, A.C. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J. Immunol. Meth. 1989, 121, 157-166.
23. 23 Goldschneider, I., Gotschlich, E.C. and Artenstein, M.S. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 1969, 129, 1307-1326.
24. 24 Goldschneider, I., Gotschlich, E.C. and Artenstein, M.S. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 1969, 129, 1327-1348.
25. 25 Christodoulides, M. and Heckels, J.E. Immunization with a multiple antigen peptide containing defined B-and T-cell epitopes: production of bactericidal antibodies against group B Neisseria meningitidis. Microbiology 1994, 140, 2951-2960.
26. 26 Satsuume-Sakai, K., Motonishi, K. and Migita, S. Quantitative estimations of five classes of immunoglobulin in inbred mouse strains. Immunology 1977, 32, 861-870.
27. 27 Hadjipetrou-Kourounakis, L. and Moller, E. Adjuvants influence the immunoglobulin subclass distribution of immune responses in vivo. Scand. J. Immunol. 1984, 19, 214-225.
28. 28 Peelers, C.C.A.M., Rümke, H.C., Sundermann, L.C., van der Voort, E.M.R., Meulenbelt, J., Schuller, M., Kuipers, A.J., van der Ley, P. and Poolman, J.T. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 1996, 14, 1009-1015.
29. 29 Zollinger, W.D. and Mandrell, RE. Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide. Infect Immun. 1983, 40, 257-264.
30. 30 Mandrell, R.E., Azmi, F.H. and Granoff, D.M. Complement-mediated bactericidal activity of human antibodies to poly α2→8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B. J. Infect Dis. 1995, 172, 1279-1289.
31. 31 Rossi-Campos, A., Anderson, C., Gerlach, G.F., Potter, A.A. and Wilson, P.J. Immunisation of pigs against Actinobacillus pleuropneumoniae with two recombinant protein preparations. Vaccine 1992, 105, 512-518.